ClinicalTrials.gg
RecruitingNCT07672093DRYNEEDUpdated Sep 24, 2026

Effects of Dry Needling on Latent Myofascial Trigger Points of the Extensor Digitorum Communis

An interventional study of Hong fast-in and fast-out dry needling and Rotational dry needling in Dry Needling Technique, Trigger Point Pain and Physical Therapy, sponsored by University Rovira i Virgili. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by University Rovira i Virgili · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 341 studies in Pain with a site in Spain — 58 open to participants now, 67 under way, 7 of them phase 3. Pain · Spain.

Planned enrollment
63rd of 295
150 · median 60
Started
2026
with 17 others
No phase
206 of 341
39 open now
Primary completion
2026-09
later than 47 of 66 live
Registered
333rd of 341
by date

Among the 341 studies in Pain with a site in Spain, this one is the 63rd largest by planned enrollment of the 295 interventional ones that give a count, is one of 18 that started in 2026, is one of 206 with no phase, reaches primary completion later than 47 of the 66 other live ones, and was the 333rd registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

58 of the 341 studies in Pain with a site in Spain are open now. Recruiting first, the newest first:

52 more — sign in →

All 58 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 341 studies in Pain with a site in Spain, or all of them as a file.
02

Study summary

This randomized single-blind clinical trial aims to compare the effects of different dry needling and electrical dry needling techniques applied to latent myofascial trigger points in the extensor digitorum muscle of the dominant forearm in healthy adults.

Participants will be randomly allocated to one of five groups: a control group, a Hong fast-in and fast-out dry needling group, a rotational dry needling group, a bipolar electrical dry needling group, or a monopolar electrical dry needling group. The main outcomes will be post-needling soreness intensity and duration. Secondary outcomes will include pain during the needling procedure, pressure pain threshold assessed by algometry, handgrip strength, range of motion of finger flexion and wrist palmar flexion, perceived comfort during the intervention, and perceived interference of post-needling soreness with daily activities.

Assessments will be performed at baseline, 5 minutes after the intervention, and at 24, 48, and 72 hours after the intervention.

Read the detailed description

Myofascial trigger points are hyperirritable spots located within a taut band of skeletal muscle. Latent myofascial trigger points do not cause spontaneous pain but may contribute to motor dysfunction, increased fatigability, reduced range of motion, and altered muscle performance. Dry needling is a commonly used physiotherapy technique for the treatment of myofascial trigger points. However, post-needling soreness is one of the most frequent adverse effects associated with this intervention and may influence patient comfort, adherence, and functional performance in the hours following treatment.

Electrical dry needling, also known as intramuscular electrical stimulation, combines dry needling with transcutaneous electrical nerve stimulation applied through the inserted needle. Different modalities of electrical dry needling are used in clinical practice, including bipolar and monopolar applications. Nevertheless, limited evidence is available regarding the effect of these techniques on post-needling soreness, particularly when short-duration monopolar stimulation is applied using a pointer-type device.

The aim of this randomized single-blind clinical trial is to compare the effects of different dry needling and electrical dry needling techniques applied to latent myofascial trigger points in the extensor digitorum muscle of the dominant forearm in healthy adults. The primary objective is to compare the effect of electrical dry needling versus Hong fast-in and fast-out dry needling on the intensity and duration of post-needling soreness. Secondary objectives include comparing post-needling soreness among the different dry needling techniques, analyzing immediate changes in handgrip strength, assessing changes in finger flexion and wrist palmar flexion range of motion, evaluating pain during the needling procedure, assessing pressure pain threshold by algometry, and analyzing perceived comfort and interference of post-needling soreness with daily activities.

Healthy adults with a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm will be recruited. Participants will be randomly assigned to one of five groups: control group, Hong fast-in and fast-out dry needling group, rotational dry needling group, bipolar electrical dry needling group, or monopolar electrical dry needling group. Participants in the control group will not receive any dry needling intervention but will undergo the same assessment schedule as the intervention groups.

In the Hong fast-in and fast-out dry needling group, a sterile needle will be inserted into the latent myofascial trigger point and repeated fast-in and fast-out movements will be performed. In the rotational dry needling group, a sterile needle will be inserted into the latent myofascial trigger point and a rotational dry needling technique will be applied according to the study protocol. In the bipolar electrical dry needling group, a sterile needle will be inserted into the latent myofascial trigger point, an adhesive electrode will be placed near the needle, and a TENS current will be applied for 15 minutes. In the monopolar electrical dry needling group, a sterile needle will be inserted into the latent myofascial trigger point and stimulation will be applied using a Pointer Plus Excel-II device for 3 minutes.

Outcome assessments will be performed at baseline and 5 minutes after the intervention. Post-needling soreness intensity and duration will also be recorded at 24, 48, and 72 hours after the intervention. The study will use separated roles for recruitment, assessment, intervention delivery, and data analysis in order to reduce bias. Outcome assessors and the researcher responsible for data analysis will be blinded to group allocation.

03

Conditions studied

  • Dry Needling Technique
  • Trigger Point Pain
  • Physical Therapy

Browse trials for

Keywords

  • dry needling
  • latent trigger point
  • physical therapy
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 40 years.
  • Healthy participants with a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.
  • No pathology affecting the upper limb where the intervention will be applied.
  • No episode of pain in the upper limb during at least the previous two months.
  • No to dry needling or electrical dry needling techniques.
  • Voluntary signature of the form.
  • Willingness to follow the protocol proposed by the research team.

Exclusion criteria

Exclusion Criteria:

  • Needle phobia.
  • Coagulation disorders.
  • Pregnancy.
  • Thyroid disorders.
  • Altered skin integrity in the treatment area.
  • Epilepsy.
  • Local or systemic infection.
  • Diagnosed neurological disorders affecting pain perception or neuromuscular function in the region of interest, such as multiple sclerosis or peripheral neuropathies.
  • Generalized chronic pain conditions, such as fibromyalgia.
  • Weekly use of analgesic medication, including anti-inflammatory drugs, opioids, or other pain-relieving medication.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • No intervention
    No Intervention: Control Group

    Participants allocated to the control group will not receive any dry needling or electrical dry needling intervention. Outcome variables will be recorded following the same assessment schedule as in the intervention groups.

  • Experimental
    Experimental: Hong Fast-In and Fast-Out Dry Needling Group

    Participants allocated to this group will receive dry needling using the fast-in and fast-out technique described by Hong, applied to a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.

    Other: Hong fast-in and fast-out dry needling

  • Experimental
    Experimental: Rotational Dry Needling Group

    Participants allocated to this group will receive dry needling using a rotational technique applied to a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.

    Other: Rotational dry needling

  • Experimental
    Experimental: Bipolar Electrical Dry Needling Group

    Participants allocated to this group will receive bipolar electrical dry needling applied to a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.

    Other: Bipolar electrical dry needling

  • Experimental
    Experimental: Monopolar Electrical Dry Needling Group

    Participants allocated to this group will receive monopolar electrical dry needling using a Pointer device, applied to a latent myofascial trigger point in the extensor digitorum muscle of the dominant forearm.

    Other: Monopolar electrical dry needling

Interventions

  • OtherHong fast-in and fast-out dry needling

    The skin will be disinfected with 0.5% alcoholic chlorhexidine. With the participant in supine position, a sterile needle will be inserted into the latent myofascial trigger point of the extensor digitorum muscle. Once the needle has reached the trigger point, 10 fast-in and fast-out movements will be performed. The number of local twitch responses will be recorded.

  • OtherRotational dry needling

    The skin will be disinfected with 0.5% alcoholic chlorhexidine. With the participant in supine position, a sterile needle will be inserted into the latent myofascial trigger point of the extensor digitorum muscle. Once the needle has reached the trigger point, the rotational dry needling technique will be applied according to the predefined study protocol.

  • OtherBipolar electrical dry needling

    The skin will be disinfected with 0.5% alcoholic chlorhexidine. With the participant in supine position, a sterile needle will be inserted into the latent myofascial trigger point of the extensor digitorum muscle. Once a local twitch response has been obtained, the needle will remain inserted and will act as the negative pole. An adhesive electrode connected to the positive pole will be placed approximately one centimeter from the needle. A TENS current will be applied for 15 minutes at a frequency of 2 Hz and a pulse width of 120 milliseconds. The intensity will be increased until visible, non-painful contractions of the extensor digitorum muscle are achieved.

  • OtherMonopolar electrical dry needling

    The skin will be disinfected with 0.5% alcoholic chlorhexidine. With the participant in supine position, a sterile needle will be inserted into the latent myofascial trigger point of the extensor digitorum muscle. Once a local twitch response has been obtained, the needle will remain inserted in the trigger point. The metallic tip of the Pointer Plus Excel-II device will be placed in contact with the needle, and a TENS current will be applied for 3 minutes at a frequency of 2 Hz and a pulse width of 220 milliseconds. The intensity will be increased until visible, non-painful contractions of the extensor digitorum muscle are achieved.

06

What researchers measure

Primary outcomes

  1. Post-needling soreness intensity

    Post-needling soreness intensity will be assessed using a numerical pain rating scale. Participants will rate the intensity of local soreness perceived in the needling area, clearly differentiated from any other type of pain. Higher scores indicate greater pain intensity.

    Time frame: 1 week

Secondary outcomes

  1. Duration of post-needling soreness

    The duration of post-needling soreness will be recorded in hours, from the moment of onset until complete disappearance, based on participant self-report during the 24-, 48-, and 72-hour follow-up assessments.

    Time frame: 1 week

  2. Pain during needling

    Pain perceived during the application of the dry needling or electrical dry needling technique will be assessed using a numerical pain rating scale. Participants will be asked to report the intensity of pain experienced during the procedure.

    Time frame: Immediately after the intervention

  3. Pressure pain threshold

    Pressure pain threshold will be assessed using pressure algometry over the treated region. The value will be recorded as the minimum pressure that induces the first sensation of pain.

    Time frame: 1 week

  4. Handgrip strength

    Handgrip strength will be assessed using a hand dynamometer and recorded in kilograms. Measurements will be performed at baseline, 5 minutes after the intervention, and 1 week after the intervention.

    Time frame: 1 week

  5. Range of motion of finger flexion and wrist palmar flexion

    Range of motion of finger flexion and wrist palmar flexion will be assessed using a two-arm goniometer and recorded in degrees.

    Time frame: 1 week

07

Study locations

1 of 1 sites recruiting
  • Facultat de Medicina i Ciències de la Salut
    Reus, Tarragona 43203, Spain
    Recruiting
08

References and documents

Publications

  • Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001 Dec;38(6):633-8. doi: 10.1067/mem.2001.118863. PubMed 11719741 ↗
  • Kalichman L, Vulfsons S. Dry needling in the management of musculoskeletal pain. J Am Board Fam Med. 2010 Sep-Oct;23(5):640-6. doi: 10.3122/jabfm.2010.05.090296. PubMed 20823359 ↗
  • Fernandez-de-Las-Penas C, Dommerholt J. International Consensus on Diagnostic Criteria and Clinical Considerations of Myofascial Trigger Points: A Delphi Study. Pain Med. 2018 Jan 1;19(1):142-150. doi: 10.1093/pm/pnx207. PubMed 29025044 ↗
  • Perreault T, Ball A, Dommerholt J, Theiss R, Fernandez-de-Las-Penas C, Butts R. Intramuscular Electrical Stimulation to Trigger Points: Insights into Mechanisms and Clinical Applications-A Scoping Review. J Clin Med. 2022 Oct 13;11(20):6039. doi: 10.3390/jcm11206039. PubMed 36294360 ↗
  • Leon-Hernandez JV, Martin-Pintado-Zugasti A, Frutos LG, Alguacil-Diego IM, de la Llave-Rincon AI, Fernandez-Carnero J. Immediate and short-term effects of the combination of dry needling and percutaneous TENS on post-needling soreness in patients with chronic myofascial neck pain. Braz J Phys Ther. 2016 Jul 11;20(5):422-431. doi: 10.1590/bjpt-rbf.2014.0176. PubMed 27410163 ↗
  • Martin-Pintado-Zugasti A, Mayoral Del Moral O, Gerwin RD, Fernandez-Carnero J. Post-needling soreness after myofascial trigger point dry needling: Current status and future research. J Bodyw Mov Ther. 2018 Oct;22(4):941-946. doi: 10.1016/j.jbmt.2018.01.003. Epub 2018 Jan 17. PubMed 30368339 ↗
  • Brady S, McEvoy J, Dommerholt J, Doody C. Adverse events following trigger point dry needling: a prospective survey of chartered physiotherapists. J Man Manip Ther. 2014 Aug;22(3):134-40. doi: 10.1179/2042618613Y.0000000044. PubMed 25125935 ↗
  • Hong CZ. Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response. Am J Phys Med Rehabil. 1994 Jul-Aug;73(4):256-63. doi: 10.1097/00002060-199407000-00006. PubMed 8043247 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Sep 2026, 2 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2026
First posted
Jun 26, 2026
StartActual
Jul 1, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Oct 15, 2026
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07672093
Lead sponsor
University Rovira i Virgili
Responsible party
Tania López Hernández (Principal Investigator, University Rovira i Virgili) — Principal investigator
First posted
Jun 26, 2026
Start date
Jul 1, 2026
Primary completion
Sep 30, 2026 (estimated)
Completion
Oct 15, 2026 (estimated)
Last update
Sep 24, 2026

Study contacts

Tania López Hernández, Phd
Contact
tania.lopez@urv.cat
34+620438175
Tania López Hernández
principal investigator · Unviersitat Rovira i Virgili

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion